APA (7th ed.) Citation

Yang, L., Cheriyan, J., Gutterman, D. D., Mayer, R. J., Ament, Z., Griffin, J. L., . . . Wilkinson, I. B. (2017). Mechanisms of Vascular Dysfunction in COPD and Effects of a Novel Soluble Epoxide Hydrolase Inhibitor in Smokers. Chest, 151(3), 555-563. https://doi.org/10.1016/j.chest.2016.10.058

Chicago Style (17th ed.) Citation

Yang, Lucy, et al. "Mechanisms of Vascular Dysfunction in COPD and Effects of a Novel Soluble Epoxide Hydrolase Inhibitor in Smokers." Chest 151, no. 3 (2017): 555-563. https://doi.org/10.1016/j.chest.2016.10.058.

MLA (9th ed.) Citation

Yang, Lucy, et al. "Mechanisms of Vascular Dysfunction in COPD and Effects of a Novel Soluble Epoxide Hydrolase Inhibitor in Smokers." Chest, vol. 151, no. 3, 2017, pp. 555-563, https://doi.org/10.1016/j.chest.2016.10.058.